1. Home
  2. OSUR vs MQT Comparison

OSUR vs MQT Comparison

Compare OSUR & MQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSUR
  • MQT
  • Stock Information
  • Founded
  • OSUR 2000
  • MQT 1992
  • Country
  • OSUR United States
  • MQT United States
  • Employees
  • OSUR N/A
  • MQT N/A
  • Industry
  • OSUR Medical/Dental Instruments
  • MQT Investment Bankers/Brokers/Service
  • Sector
  • OSUR Health Care
  • MQT Finance
  • Exchange
  • OSUR Nasdaq
  • MQT Nasdaq
  • Market Cap
  • OSUR 248.3M
  • MQT 225.3M
  • IPO Year
  • OSUR 1986
  • MQT N/A
  • Fundamental
  • Price
  • OSUR $3.10
  • MQT $9.92
  • Analyst Decision
  • OSUR Hold
  • MQT
  • Analyst Count
  • OSUR 2
  • MQT 0
  • Target Price
  • OSUR $5.50
  • MQT N/A
  • AVG Volume (30 Days)
  • OSUR 682.8K
  • MQT 52.5K
  • Earning Date
  • OSUR 05-07-2025
  • MQT 01-01-0001
  • Dividend Yield
  • OSUR N/A
  • MQT 4.60%
  • EPS Growth
  • OSUR N/A
  • MQT N/A
  • EPS
  • OSUR N/A
  • MQT N/A
  • Revenue
  • OSUR $185,827,000.00
  • MQT N/A
  • Revenue This Year
  • OSUR N/A
  • MQT N/A
  • Revenue Next Year
  • OSUR $7.46
  • MQT N/A
  • P/E Ratio
  • OSUR N/A
  • MQT N/A
  • Revenue Growth
  • OSUR N/A
  • MQT N/A
  • 52 Week Low
  • OSUR $2.69
  • MQT $8.59
  • 52 Week High
  • OSUR $6.35
  • MQT $10.67
  • Technical
  • Relative Strength Index (RSI)
  • OSUR 37.03
  • MQT 45.15
  • Support Level
  • OSUR $3.34
  • MQT $10.04
  • Resistance Level
  • OSUR $3.38
  • MQT $10.15
  • Average True Range (ATR)
  • OSUR 0.14
  • MQT 0.10
  • MACD
  • OSUR -0.02
  • MQT 0.00
  • Stochastic Oscillator
  • OSUR 0.88
  • MQT 27.14

About OSUR OraSure Technologies Inc.

OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.

About MQT Blackrock MuniYield Quality Fund II Inc.

BLACKROCK MUNIYIELD QUALITY FUND II, INC. is a closed-end fund. Its objective is to provide shareholders with as high a level of current income exempt from federal income taxes as is consistent with its investment policies and prudent investment management. It invests in various sectors such as Transportation, Utilities, Health, County/City/Special District/School District, Education, and Housing.

Share on Social Networks: